NCT02734979View on ClinicalTrials.gov

Prospective Evaluation of a Surgical Solution for Breast Cancer-Associated Lymphedema

NACompletedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

July 20, 2016

Primary Completion Date

July 7, 2018

Study Completion Date

October 29, 2020

Conditions
LymphedemaEdema
Interventions
DEVICE

Biobridge and lymph node transfer

Biobridge is surgically implanted with conventional vascularized lymph node transfer surgery

Trial Locations (1)

94305

Stanford University, Stanford

All Listed Sponsors
lead

Stanford University

OTHER

NCT02734979 - Prospective Evaluation of a Surgical Solution for Breast Cancer-Associated Lymphedema | Biotech Hunter | Biotech Hunter